# A Placebo Controlled Trial of Dalfampridine ER for Ambulatory Activity in People With Multiple Sclerosis

> **NCT01356940** · PHASE4 · COMPLETED · sponsor: **Brown, Theodore R., M.D., MPH** · enrollment: 43 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** dalfampridine ER
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01356940
- **Lead sponsor:** Brown, Theodore R., M.D., MPH
- **Sponsor class:** INDIV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2018-10-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01356940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01356940, "A Placebo Controlled Trial of Dalfampridine ER for Ambulatory Activity in People With Multiple Sclerosis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01356940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*